Drug Profile
Research programme: CNS disorder therapies - Kyoto University/Shionogi
Alternative Names: Alzheimer's disease therapeutics - Kyoto University/Shionogi; Psychiatric disorder therapeutics - Kyoto University/Shionogi; SK ProjectLatest Information Update: 28 Apr 2022
Price :
$50
*
At a glance
- Originator Kyoto University; Shionogi
- Class Antipsychotics
- Mechanism of Action Central nervous system modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease; Psychiatric disorders
Most Recent Events
- 28 Apr 2022 No recent reports of development identified for research development in Psychiatric-disorders in Japan
- 26 Mar 2018 Kyoto University and Shionogi enter a research collaboration to develop Psychiatric disorder therapeutics
- 26 Mar 2018 Early research in Psychiatric disorders in Japan (unspecified route)